statistiche ricercatore

Continente	#
NA - Nord America	361
AS - Asia	182
EU - Europa	182
SA - Sud America	49
Continente sconosciuto - Info sul continente non disponibili	43
AF - Africa	10
OC - Oceania	2
Totale	829

Nazione	#
US - Stati Uniti d'America	340
IT - Italia	60
SG - Singapore	60
BR - Brasile	41
CN - Cina	35
NO - Norvegia	24
HK - Hong Kong	23
RU - Federazione Russa	23
FI - Finlandia	13
VN - Vietnam	12
SE - Svezia	11
IN - India	10
BD - Bangladesh	9
DE - Germania	9
FR - Francia	9
CA - Canada	8
ES - Italia	8
AT - Austria	7
MX - Messico	5
PK - Pakistan	5
GB - Regno Unito	4
ID - Indonesia	4
IQ - Iraq	4
AR - Argentina	3
CO - Colombia	3
JP - Giappone	3
MY - Malesia	3
NL - Olanda	3
SV - El Salvador	3
UZ - Uzbekistan	3
ZA - Sudafrica	3
BE - Belgio	2
GE - Georgia	2
LT - Lituania	2
MA - Marocco	2
OM - Oman	2
PL - Polonia	2
TR - Turchia	2
AL - Albania	1
AU - Australia	1
BW - Botswana	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
GP - Guadalupe	1
HU - Ungheria	1
IE - Irlanda	1
JM - Giamaica	1
KG - Kirghizistan	1
LB - Libano	1
NI - Nicaragua	1
NZ - Nuova Zelanda	1
PH - Filippine	1
PR - Porto Rico	1
PY - Paraguay	1
RW - Ruanda	1
SA - Arabia Saudita	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
TW - Taiwan	1
UA - Ucraina	1
VE - Venezuela	1
Totale	786

Nome	#
G-protein coupled receptors involved in the resolution of inflammation: Ligands and therapeutic perspectives	189
Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists	150
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors	114
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1–42)-Induced Neuroinflammation in Mouse Models of Alzheimer’s Disease	107
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders	107
Design and Synthesis of Arylpiperazine Serotonergic/ Dopaminergic Ligands with Neuroprotective Properties	91
Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder	71
Totale	829

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	28	0	0	0	0	0	5	0	0	11	2	2	8
2022/2023	19	3	3	1	2	4	3	0	1	1	0	1	0
2023/2024	17	1	1	0	1	1	5	0	0	0	3	1	4
2024/2025	160	2	0	9	4	2	11	48	20	6	5	22	31
2025/2026	457	64	36	32	40	54	24	55	12	48	47	13	32
2026/2027	84	7	16	27	28	6	0	0	0	0	0	0	0
Totale													829